AZR1 Antibody

Shipped with Ice Packs
In Stock

Description

Potential Nomenclature Clarification

The term "AZR1" does not correspond to any established gene symbol, protein designation, or antibody target in current biomedical databases (e.g., UniProt, HUGO Gene Nomenclature Committee). Possible scenarios include:

  • Typographical Error: The query may refer to ADAR1 (Adenosine Deaminase Acting on RNA 1) or ACVR1 (Activin A Receptor Type 1), both of which are well-characterized targets with commercially available antibodies.

  • Obsolete Terminology: "AZR1" could represent outdated nomenclature for a receptor or enzyme not widely recognized in contemporary literature.

ADAR1 Antibodies

ADAR1 is an RNA-editing enzyme critical for post-transcriptional modification. Key findings from the search results include:

AntibodyApplicationsSpecies ReactivityKey FeaturesSource
Anti-ADAR1 [EPR25431-60]Western blot, IHCHuman, Mouse, RatBinds specifically to ADAR1 (150 kDa); validated in knockout cell lines .Abcam
Anti-ADAR1 (A97053)IHC, ELISAHuman, Mouse, RatTargets residues 1172–1221; pre-adsorption controls available .Antibodies.com

Research Findings:

  • ADAR1 edits RNA substrates such as BLCAP, GRIA2, and HTR2C, altering protein function .

  • Plays dual roles in viral infections: proviral (e.g., HIV-1) and antiviral (e.g., HCV) .

ACVR1 Antibodies

ACVR1 is a bone morphogenetic protein (BMP) receptor implicated in heterotopic ossification (HO). Key insights:

AntibodyApplicationsSpecies ReactivityKey FindingsSource
Anti-ACVR1 (JAB0505)In vitro/in vivo modelsMouse, HumanExacerbates HO in FOP mice via agonistic activity on mutant ACVR1 .PMC
Anti-ACVR1 (mAb 1)Functional assaysHuman, MouseBlocks WT ACVR1 but activates mutant ACVR1(R206H), worsening HO .PMC

Mechanistic Insights:

  • Anti-ACVR1 antibodies unexpectedly aggravate HO in fibrodysplasia ossificans progressiva (FOP) models by promoting osteogenic differentiation of fibro-adipogenic progenitors (FAPs) .

  • Fragment antigen-binding (Fab) regions of these antibodies show therapeutic potential in inhibiting HO .

Recommendations for Further Inquiry

  1. Verify Target Specificity: Confirm whether "AZR1" corresponds to ADAR1, ACVR1, or another receptor/enzyme.

  2. Explore Orthogonal Databases: Consult resources like the Human Protein Atlas or CiteAb for antibody validation data.

  3. Consider Functional Analogues: If studying RNA editing or HO, prioritize ADAR1 or ACVR1 antibodies with established roles in these pathways.

Limitations of Current Data

  • No peer-reviewed studies or commercial products reference "AZR1 Antibody."

  • Potential mismatches in nomenclature underscore the need for precise terminology in antibody research.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AZR1 antibody; YGR224W antibody; G8537Azole resistance protein 1 antibody
Target Names
AZR1
Uniprot No.

Target Background

Function
AZR1 Antibody targets a transporter protein crucial for adaptation to high stress conditions induced by short-chain organic acids, particularly acetic acid. Additionally, this antibody plays a role in conferring resistance to azoles, specifically ketoconazole and fluconazole.
Database Links

KEGG: sce:YGR224W

STRING: 4932.YGR224W

Protein Families
Major facilitator superfamily
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is AZR1 and what are the key considerations when selecting an antibody against it?

AZR1 (Acetic acid and Zinc Resistance 1) is a transmembrane transporter protein identified in yeasts including Saccharomyces cerevisiae (gene YGR224W) and Schizosaccharomyces pombe (gene SPAC1556.03) . The protein plays a critical role in stress response mechanisms, particularly adaptation to short-chain organic acids and zinc stress conditions.

When selecting antibodies against AZR1, researchers should consider:

  • Species specificity: Ensure the antibody recognizes your specific yeast species (S. cerevisiae or S. pombe)

  • Application compatibility: Verify validation for your intended application (Western blot, immunofluorescence, etc.)

  • Epitope location: For membrane proteins like AZR1, antibodies targeting extracellular domains may be preferable for certain applications

  • Validation method: Look for antibodies validated in knockout systems to confirm specificity

What experimental applications are suitable for AZR1 antibodies?

AZR1 antibodies can be employed in multiple experimental contexts:

ApplicationRecommended DilutionSpecial Considerations
Western blotting1:500-1:1000Sample preparation requires membrane protein extraction protocols
Immunofluorescence1:100-1:500Requires specialized yeast cell wall digestion
Immunoprecipitation2-5 μg/mg proteinUse detergents optimized for membrane proteins
Flow cytometry1:50-1:200Requires effective cell permeabilization

For membrane proteins like AZR1, standard protocols often require modification. Special attention should be paid to membrane solubilization using appropriate detergents such as digitonin or n-dodecyl-β-D-maltoside (DDM) during sample preparation .

How can I validate the specificity of an AZR1 antibody?

Proper validation is crucial for generating reliable data with AZR1 antibodies:

  • Genetic validation: The gold standard approach is comparing antibody reactivity between wild-type yeast and AZR1 knockout strains . The absence of signal in knockout strains confirms specificity.

  • Recombinant expression: Express tagged AZR1 in yeast and confirm co-localization of antibody signal with the tag detection .

  • Peptide competition: Pre-incubate the antibody with the immunizing peptide before application. Specific signals should be blocked by this treatment .

  • Cross-reactivity assessment: Test the antibody against related transporter proteins to ensure specificity within the protein family.

  • Western blot molecular weight confirmation: Verify the detected band matches the predicted molecular weight of AZR1 (~65 kDa) with appropriate controls for glycosylation or other post-translational modifications.

How can AZR1 antibodies be utilized to study stress response mechanisms in yeast?

AZR1's role in stress adaptation makes it an excellent model for studying cellular stress responses:

  • Stress induction time course:

    • Expose yeast cultures to relevant stressors (acetic acid at 0.1-0.5% or excess zinc)

    • Collect samples at defined intervals (0, 15, 30, 60, 120 minutes post-exposure)

    • Analyze AZR1 expression and localization changes using validated antibodies

  • Subcellular fractionation analysis:

    • Separate membrane fractions from cytosolic components

    • Quantify changes in AZR1 distribution between fractions during stress response

    • Correlate with cell survival metrics to establish functional relationships

  • Signaling pathway interrogation:

    • Combine AZR1 antibody detection with analysis of known stress response pathways

    • ASK1 (Apoptosis Signal-regulating Kinase 1) signaling is particularly relevant as it mediates responses to various stressors including oxidative stress

    • Compare AZR1 expression patterns in wild-type versus ASK1-deficient cells

The MAP kinase pathways, particularly those involving p38 and JNK activation, interface with membrane transporters during stress response. Research has shown that ASK1 regulates p38/JNK signaling during cellular stress, which may interact with AZR1 function .

What are the optimal protocols for immunoprecipitating AZR1 to study protein interactions?

Immunoprecipitating membrane proteins like AZR1 presents unique challenges requiring specialized protocols:

Optimized co-immunoprecipitation protocol for AZR1:

  • Cell preparation and lysis:

    • Grow yeast to mid-log phase (OD600 of 0.6-0.8)

    • For stress response studies, apply appropriate stressor 30-60 minutes before harvest

    • Prepare spheroplasts using zymolyase (1 mg/ml, 30 minutes at 30°C)

    • Lyse cells in buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 1% digitonin or DDM

    • Include protease and phosphatase inhibitor cocktails

    • Maintain samples at 4°C throughout processing

  • Immunoprecipitation:

    • Pre-clear lysate with Protein A/G beads for 1 hour

    • Incubate with 2-5 μg AZR1 antibody per mg of protein (overnight, 4°C)

    • Add fresh Protein A/G beads and incubate for additional 3 hours

    • Wash 5 times with decreasing detergent concentration (0.5% to 0.1%)

  • Elution and analysis:

    • Elute bound proteins with pH gradient or SDS sample buffer (avoid boiling)

    • Analyze by Western blot or mass spectrometry

This approach has been effectively used for membrane transporters and can be adapted for AZR1 to identify novel interaction partners involved in stress response pathways .

How do I optimize immunofluorescence techniques for visualizing AZR1 in yeast cells?

Visualizing membrane proteins in yeast requires specialized immunofluorescence approaches:

  • Cell wall removal and fixation:

    • Convert yeast to spheroplasts using optimized zymolyase treatment

    • Fix cells with 4% paraformaldehyde (10-15 minutes)

    • For S. pombe, longer digestion times may be necessary compared to S. cerevisiae

  • Membrane permeabilization optimization:

    • Test a gradient of detergent concentrations (0.05%-0.5% Triton X-100)

    • For membrane proteins, saponin (0.1%) often provides better epitope preservation

    • Optimize time and temperature for permeabilization

  • Blocking and antibody incubation:

    • Block with 3-5% BSA in PBS with 0.1% detergent (1 hour)

    • Incubate with primary AZR1 antibody (typically 1:100-1:500) overnight at 4°C

    • Use fluorescently-labeled secondary antibodies at manufacturer's recommended dilution

  • Controls and co-localization:

    • Include membrane markers for co-localization studies

    • Use AZR1 knockout strains as negative controls

    • Consider AZR1-tagged constructs as positive controls

The challenges in immunofluorescence detection of AZR1 are similar to those faced when studying other yeast membrane proteins, requiring careful optimization of each step .

How can I use antibodies to investigate post-translational modifications of AZR1?

Post-translational modifications (PTMs) often regulate transporter function and can be studied using antibody-based approaches:

  • Phosphorylation analysis:

    • Immunoprecipitate AZR1 using validated antibodies

    • Analyze by Western blot with phospho-specific antibodies

    • Alternatively, use phospho-protein enrichment followed by AZR1 detection

    • Include λ-phosphatase treatment as a control

  • Ubiquitination detection:

    • Perform denaturing immunoprecipitation to disrupt protein interactions

    • Probe with anti-ubiquitin antibodies

    • Consider proteasome inhibitor treatment to enhance detection

  • Sample preparation considerations:

    • Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride)

    • Add deubiquitinase inhibitors (N-ethylmaleimide)

    • Maintain low temperature throughout processing

  • PTM site identification:

    • After immunoprecipitation with AZR1 antibodies, perform mass spectrometry

    • Compare PTM patterns under different stress conditions

    • Correlate with functional changes in AZR1 activity

Understanding AZR1 post-translational modifications can provide critical insights into how this transporter is regulated during stress responses .

What are the main technical challenges when working with AZR1 antibodies across different yeast species?

Working with AZR1 antibodies across S. cerevisiae and S. pombe presents several challenges:

ChallengeSolutionTechnical Details
Sequence variations between speciesUse antibodies targeting conserved epitopesSequence alignment shows 62% similarity in the conserved domains
Different extraction efficienciesOptimize lysis protocols for each speciesS. pombe typically requires stronger mechanical disruption
Variable expression levelsAdjust antibody dilutions by speciesExpression may be 2-3× higher in S. cerevisiae under standard conditions
Cross-reactivity concernsValidate specificity in each speciesUse respective knockout strains as controls

A comprehensive validation approach in both species includes:

  • Testing antibody performance in wild-type and knockout strains of each species

  • Comparing recognition of recombinant proteins from both yeasts

  • Optimizing fixation and extraction conditions separately for each species

How can I develop a yeast display system to screen for high-affinity AZR1 antibodies?

Yeast display technology offers powerful approaches for antibody development against challenging targets like AZR1:

  • Library construction and screening strategy:

    • Generate a diverse antibody library (10⁹-10¹⁰ members) using techniques described in recent publications

    • Display antibody fragments (scFv or Fab) on yeast surface fused to Aga2p protein

    • Express recombinant AZR1 domains as screening targets

  • Technical optimization for membrane protein targets:

    • Express properly folded AZR1 domains by incorporating membrane mimetics

    • Use detergent-solubilized or nanodiscs-incorporated AZR1 as target

    • Include biotinylated target protein for detection with fluorescent streptavidin

  • Selection process:

    • Perform multiple rounds of magnetic and flow cytometric sorting

    • Gradually increase selection stringency

    • Counter-select against related transporters to ensure specificity

  • Validation of selected antibodies:

    • Express and purify selected antibody candidates

    • Test binding to native AZR1 in yeast cells

    • Verify specificity using knockout controls

Recent advancements in yeast display technology have enabled the development of antibodies against challenging membrane protein targets, making this approach feasible for AZR1 .

How do growth conditions affect AZR1 expression and what implications does this have for antibody detection?

AZR1 expression varies significantly under different conditions, affecting antibody detection:

Growth ConditionExpected AZR1 ExpressionAntibody Dilution AdjustmentRationale
Standard media (YPD/YES)Low/Basal1:500Constitutive expression level
Acetic acid stress (0.1-0.5%)High (3-5× increase)1:1000-1:2000Transporter upregulation for adaptation
Zinc stress conditionsModerate-High1:1000Secondary function in zinc transport
Stationary phaseModerate1:750Stress response activation

For accurate experimental planning:

  • Include appropriate positive controls from cells under stress conditions

  • Design time-course experiments to capture transient expression changes

  • Consider adjusting antibody concentrations based on expected expression levels

  • Use loading controls appropriate for membrane proteins

This response pattern aligns with AZR1's role in adapting to environmental stresses through modified membrane transport activity .

How can I distinguish between AZR1 and other related transporters when using antibodies?

Ensuring specificity when detecting AZR1 versus related transporters requires careful experimental design:

  • Cross-reactivity assessment:

    • Test antibody against lysates from cells expressing related transporters

    • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

    • Compare binding patterns between wild-type and AZR1 knockout strains

  • Epitope mapping and selection:

    • Choose antibodies targeting unique regions of AZR1 not conserved in related transporters

    • Consider generating custom antibodies against specific AZR1 domains

    • Use peptide competition assays with AZR1-specific peptides

  • Validation strategy:

    • Express epitope-tagged AZR1 in yeast

    • Compare antibody detection with tag-specific antibody detection

    • Verify signals disappear in knockout strains

  • Controls for experiments:

    • Include samples from cells overexpressing related transporters

    • Use gradient SDS-PAGE to resolve proteins of similar molecular weights

    • Consider 2D gel electrophoresis for complex samples

This approach is particularly important given that yeast genomes encode multiple transporters with similar structures and functions .

How do AZR1 and ASK1 pathways interact during cellular stress responses?

The potential relationship between AZR1 (a membrane transporter) and ASK1 (a key stress response kinase) represents an interesting area for investigation:

  • Signaling pathway integration:

    • ASK1 is activated by various stressors including oxidative stress and inflammatory signals

    • ASK1 activates downstream MAPK pathways (p38 and JNK)

    • AZR1 expression and activity may be regulated by these stress-activated pathways

  • Experimental approach to investigate interactions:

    • Compare AZR1 expression and localization in wild-type versus ASK1-deficient cells

    • Analyze phosphorylation status of AZR1 after stress induction

    • Test if ASK1 inhibitors affect AZR1 transport activity

  • Potential mechanism of interaction:

    • ASK1 signaling may phosphorylate AZR1 directly or via downstream kinases

    • Altered AZR1 activity could affect intracellular pH or ion concentrations, feeding back to ASK1 pathways

    • Both proteins contribute to stress adaptation through potentially complementary mechanisms

Research has shown that ASK1 plays critical roles in responses to various cellular stresses, including those that would activate membrane transporters like AZR1 .

How can antibodies help determine AZR1's role in adaptation to different stress conditions?

Antibody-based approaches can dissect AZR1's specific contributions to stress adaptation:

  • Expression pattern analysis:

    • Use AZR1 antibodies to quantify protein levels under different stress conditions

    • Compare expression kinetics across multiple stressors (acetic acid, zinc, oxidative stress)

    • Correlate with cell survival metrics to establish functional relationships

  • Localization studies:

    • Track AZR1 subcellular distribution during stress response

    • Identify potential re-localization events that correlate with adaptation

    • Co-localize with other stress response proteins to identify functional complexes

  • Protein interaction networks:

    • Immunoprecipitate AZR1 at different time points during stress response

    • Identify dynamic interaction partners using mass spectrometry

    • Map AZR1-centered protein networks that mediate adaptation

  • Functional inhibition studies:

    • Test whether function-blocking AZR1 antibodies affect stress survival

    • Compare with genetic knockout effects to distinguish direct versus compensatory effects

These approaches can reveal how AZR1 integrates into broader cellular stress response mechanisms, particularly related to membrane transport regulation .

How can chemically diversified antibody libraries improve functional studies of AZR1?

Recent advances in antibody engineering offer new possibilities for studying AZR1 function:

  • Chemically expanded antibody libraries:

    • Recent research has developed billion-member antibody libraries with non-canonical amino acids

    • These modified antibodies can incorporate reactive groups capable of:

      • Photo-crosslinking to capture transient interactions

      • Click chemistry for targeted labeling

      • Proximity-induced reactions for activity studies

  • Functional applications for AZR1 research:

    • Developing antibodies that can irreversibly bind active conformations of AZR1

    • Creating antibodies that can report on AZR1 transport activity

    • Designing antibodies that modulate transporter function

  • Technical considerations:

    • Screening can be performed using yeast display systems

    • Flow cytometry enables high-throughput selection of antibodies with desired properties

    • Biochemical validation requires careful characterization of binding and functional effects

This approach could yield research tools that go beyond simple detection, providing reagents that report on or manipulate AZR1 functional states .

What are the best approaches for developing phospho-specific antibodies against AZR1?

Developing phospho-specific antibodies for AZR1 requires specialized approaches:

  • Phosphorylation site identification:

    • Perform phosphoproteomic analysis of AZR1 under various conditions

    • Prioritize sites showing dynamic regulation during stress response

    • Consider evolutionary conservation of phosphorylation sites

  • Custom antibody development strategy:

    • Design phosphopeptides containing the phosphorylation site of interest

    • Synthesize both phosphorylated and non-phosphorylated peptides

    • Immunize with phosphopeptide conjugated to carrier protein

    • Deplete non-phospho-specific antibodies by absorption with non-phosphorylated peptide

  • Validation requirements:

    • Test antibody against wild-type and phospho-site mutant AZR1 (S/T→A or Y→F)

    • Verify phosphatase treatment eliminates signal

    • Confirm specificity using peptide competition

  • Applications:

    • Monitor AZR1 phosphorylation status during stress adaptation

    • Identify conditions that trigger specific phosphorylation events

    • Correlate phosphorylation with changes in transporter activity

Phospho-specific antibodies would provide valuable tools for understanding how post-translational modifications regulate AZR1 function during stress responses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.